Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05350878 · ClinicalTrials.gov registry record · NA
Implementing Mobile Technology for Unhealthy Alcohol Use
A NA study of Alcohol Drinking, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 1
- Study location
NCT05350878: Completed NA study of Alcohol Drinking, sponsored by UConn Health.
NCT05350878 is a NA study of Alcohol Drinking that has completed, run by UConn Health. The registered enrollment target is 344 participants, below the 626-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05350878, a NA study of Alcohol Drinking, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 1
- Study location
Study Summary
Scalable approaches are needed to support patients identified in the emergency department as unhealthy alcohol users and text messaging intervention approaches are a promising solution. However, the process of providers making text messing interventions for unhealthy alcohol use available to patients in an efficient way within already busy and overburdened emergency department workflows (i.e., implementation in real-world emergency department settings) and patients adopting them remains a new area of research. Study investigators will examine barriers and facilitators to the adoption of text messaging interventions for unhealthy alcohol use in emergency departments and use a stakeholder-engaged process to develop and test practical implementation strategies that could provide much needed support to patients who screen positive while reducing burden on emergency departments.
Primary Outcome
The proportion of eligible patients who enrolled in the alcohol text messaging intervention in the implementation intervention and the control condition.
Conditions Studied
Interventions
- OTHER Implementation Intervention
Study Locations (1)
New York
- Northwell Health - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What the finished NCT05350878 record still lists
NCT05350878 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, below the 626-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Implementation Intervention is the first listed.
NCT05350878 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05350878 about?
NCT05350878 is a clinical study titled "Implementing Mobile Technology for Unhealthy Alcohol Use". Scalable approaches are needed to support patients identified in the emergency department as unhealthy alcohol users and text messaging intervention approaches are a promising solution. However, the process of providers making text messing interventions for unhealthy alcohol use available to patient...
What is the current status of trial NCT05350878?
This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2023-10-01. Estimated completion is 2024-12-01.
What conditions does trial NCT05350878 study?
This clinical trial studies the following conditions: Alcohol Drinking.
What interventions are being tested in trial NCT05350878?
The interventions under investigation include: Implementation Intervention (OTHER).
Who is sponsoring clinical trial NCT05350878?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05350878 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05350878's enrollment target sits among peer trials
344 29th of 85 higher than 57 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI